Publications by Dr Daniel Felmlee - ePrints

Browsing publications by Dr Daniel Felmlee.

Newcastle Authors	Title	Year
Dr David Sheridan Dr Daniel Felmlee Dr Simon Bridge Emeritus Professor Margaret Bassendine	Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis	2022
Emeritus Professor Margaret Bassendine Dr Soren Nielsen Dr Simon Bridge Dr Daniel Felmlee Dr David Sheridan et al.	Hepatitis C virus and atherosclerosis: A legacy after virologic cure?	2017
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Emeritus Professor Margaret Bassendine	Lipidomics analysis of fasting serum identifies novel lipid biomarkers specific for HCV genotype 3 and genotype 1 chronic hepatitis C virus infection	2015
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Fiona Fenwick Dr Clare Lanyon et al.	PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism	2015
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Dr R Neely Emeritus Professor Margaret Bassendine et al.	Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency	2014
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Fiona Fenwick Dr R Neely et al.	Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial	2014
Professor Margaret Bassendine Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Dr R Neely et al.	Lipids and HCV	2013
Dr David Sheridan Dr Daniel Felmlee Dr Simon Bridge Fiona Fenwick Emeritus Professor Geoffrey Toms et al.	Metabolic Syndrome and Insulin Resistance are Associated with Maximum Hepatitis C Lipoviral Particles in Genotype 1 Infection	2013
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Fiona Fenwick Professor Margaret Bassendine et al.	Omega-3 Fatty Acids and/or Fluvastatin in Hepatitis C Prior Non-Responders to Combination Anti-Viral Therapy - A Pilot Randomised Clinical Trial	2013
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Emeritus Professor Geoffrey Toms Dr R Neely et al.	Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: Evidence for an association with interferon sensitivity	2012
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Emeritus Professor Geoffrey Toms Professor Margaret Bassendine et al.	Apolipoprotein E and low-density, apolipoprotein B associated lipoviral particles in chronic Hepatitis C infection: Evidence for genotype-specific modulation of lipid pathways	2011
Professor Margaret Bassendine Dr David Sheridan Dr Daniel Felmlee Dr Simon Bridge Emeritus Professor Geoffrey Toms et al.	HCV and the hepatic lipid pathway as a potential treatment target	2011
Dr Daniel Felmlee Dr David Sheridan Dr Simon Bridge Emeritus Professor Geoffrey Toms Professor Margaret Bassendine et al.	Use of intralipid infusion to analyse apolipoprotein B (APOB) and HCV RNA kinetics in chronic infection	2011
Dr David Sheridan Professor Kim Bartlett Dr Daniel Felmlee Dr Simon Bridge Emeritus Professor Geoffrey Toms et al.	Hypocholesterolaemia in chronic hepatitis C genotype 3 infection is due to both reduced cholesterol production and increased LDL clearance	2010
Dr David Sheridan Professor Kim Bartlett Dr Daniel Felmlee Dr Simon Bridge Emeritus Professor Geoffrey Toms et al.	Hypocholesterolaemia in chronic Hepatitis C virus (HCV) infection - Reduced production or increased LDL clearance?	2010
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Dr Soren Nielsen Dr R Neely et al.	Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection	2010
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Dr Soren Nielsen Dr R Neely et al.	Insulin resistance correlates with low density hepatitis C virus particles in genotype 1 infection	2010
Dr Daniel Felmlee Dr David Sheridan Dr Simon Bridge Dr Soren Nielsen Emeritus Professor Geoffrey Toms et al.	Intravascular Transfer Contributes to Postprandial Increase in Numbers of Very-Low-Density Hepatitis C Virus Particles	2010
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Emeritus Professor Geoffrey Toms Dr R Neely et al.	Low density Hepatitis C virus particles (lipoviral particles) associate with insulin resistance in genotype 1 infection	2010
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Emeritus Professor Geoffrey Toms Professor Margaret Bassendine et al.	Measurement of low-density Apolipoprotein B associated lipoviral particles in hepatitis C virus genotype 1 infection is more clinically relevant than total viral load	2010
Dr Daniel Felmlee Dr David Sheridan Dr Simon Bridge Emeritus Professor Geoffrey Toms Professor Margaret Bassendine et al.	The HCV life-cycle in the vascular compartment	2010
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Dr Soren Nielsen Emeritus Professor Geoffrey Toms et al.	Apolipoprotein B Associated Hepatitis C Virus (HCV): A Minority of Total Viral Load in Patients with Chronic HCV	2009
Dr Daniel Felmlee Dr Simon Bridge Dr David Sheridan Dr Soren Nielsen Emeritus Professor Geoffrey Toms et al.	Large and Buoyant Hepatitis C Virus (HCV) Particles Surge after Patients Consume a High-Fat Meal	2009
Dr Daniel Felmlee	Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress.	2007
Dr Daniel Felmlee	Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion.	2005